Intuitive Surgical, Inc.

NASDAQ Global Select
Back to all articles
Somewhat Bullish +30

Bank of New York Mellon Corp Sells 369,852 Shares of Intuitive Surgical ...

📉 Bank of New York Mellon Corp sold 369,852 shares of ISRG in Q1, reducing its position by 9.4% while retaining a stake worth $1.637 billion.

📈 Several smaller institutional investors increased their stakes in Q4, including Newbridge Financial Services Group which lifted holdings by 300%.

💰 Intuitive Surgical reported quarterly revenue of $2.77 billion, beating analyst estimates of $2.62 billion by $150 million.

📊 The company posted EPS of $2.50, surpassing the consensus estimate of $2.08 and achieving a net margin of 28.15%.

🚀 Revenue grew 23% year-over-year, demonstrating continued strong demand for robotic surgical systems.

📝 Citigroup reissued a 'buy' rating on ISRG, while Goldman Sachs set a price objective of $558.

⚠️ Jefferies Financial Group cut its price target to $515 and downgraded the stock to a 'hold' rating.

🎯 Piper Sandler reaffirmed an 'overweight' rating with a price target of $580 on ISRG shares.

📉 The consensus analyst target price for Intuitive Surgical is currently set at $565.31.

📈 The stock trades at a P/E ratio of 47.15 with a market capitalization of $137.76 billion.

🏥 ISRG specializes in da Vinci surgical systems that enable minimally invasive procedures for hospitals.

📉 The stock price has fluctuated between a twelve-month low of $378.50 and a high of $603.88.

Bullish Signals
  • Intuitive Surgical beat quarterly earnings estimates significantly, reporting $2.50 EPS versus the consensus of $2.08.
  • Revenue growth remains robust at 23% year-over-year, reaching $2.77 billion for the quarter.
  • The company maintains healthy profitability with a net margin of 28.15% and a return on equity of 15.98%.
  • Citigroup reissued a 'buy' rating on ISRG, reinforcing positive analyst sentiment.
  • Piper Sandler reaffirmed an 'overweight' rating with a price target of $580.
  • Analyst consensus remains 'Moderate Buy' with a collective target price of $565.31.
Risk Factors
  • Jefferies Financial Group cut its price objective to $515 and assigned a 'hold' rating, indicating some caution.
  • Raymond Financial reduced its price target from $615 to $577 despite maintaining an 'outperform' rating.
  • BNY Mellon's significant reduction in holdings by 9.4% suggests institutional investors are trimming exposure.
  • The stock trades at a high P/E ratio of 47.15, which may limit upside potential if growth slows.
Full Analysis
Bank of New York Mellon Corp reduced its stake in Intuitive Surgical, Inc. (ISRG) by 9.4% during the first quarter, selling 369,852 shares. Following this transaction, BNY Mellon holds approximately 1.00% of the company's stock, valued at $1.637 billion. While major institutions trim positions, several smaller hedge funds and wealth management firms increased their holdings in the fourth quarter, though these new stakes are relatively minor in total value compared to the large institutional owner. Analyst sentiment regarding ISRG remains mixed but generally positive, with a consensus rating of 'Moderate Buy' and a target price of $565.31. Recent analyst actions include Citigroup reissuing a 'buy' rating, Goldman Sachs setting a $558 price objective, and Piper Sandler reaffirming an 'overweight' rating with a $580 target. Conversely, Jefferies Financial Group cut its price objective to $515 and assigned a 'hold' rating, while Raymond James lowered its target to $577. Intuitive Surgical reported strong financial performance in the quarter ended April 21st, posting earnings per share of $2.50 against a consensus estimate of $2.08. Revenue reached $2.77 billion, representing a 23% year-over-year increase compared to analyst expectations of $2.62 billion. The company achieved a net margin of 28.15% and a return on equity of 15.98%, with equities research analysts forecasting an EPS of 8.57 for the current fiscal year. The medical technology company, headquartered in Sunnyvale, California, specializes in robotic-assisted surgical systems like the da Vinci platform. With a market capitalization of $137.76 billion and a P/E ratio of 47.15, ISRG trades above its 200-day simple moving average of $469.98 but below its 50-day average of $418.39. The stock has seen significant volatility over the past year, ranging from a low of $378.50 to a high of $603.88.